Yearender
Indian Athletics in 2025: Neeraj hits 90m high but no end to country's doping woes
Eye on USD 500 bn by 2047, pharma sector steps into 2026 with innovation on agenda
Indian football hits new low in 2025 as ISL crisis deepens, results collapse
Yearender 2025: Oil is king again, with India driving global demand comeback
Yearender 2025: From MUFG to Emirates NBD, foreign money flows into Indian finance
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/P1zTZZUuvtG6Ew6WYZWl.jpg)
/newsdrum-in/media/media_files/2025/07/05/neeraj-choprawin-2025-07-05-23-13-20.jpeg)
/newsdrum-in/media/media_files/2025/09/26/indian-pharma-stocks-pharmaceutical-pharmacy-medicines-drugs-vaccine-2025-09-26-18-00-42.jpg)
/newsdrum-in/media/media_files/2025/03/26/3HBWUFmDP8QpGngBDKKo.jpg)
/newsdrum-in/media/media_files/IvqCBazNkAD0mMrM8SMe.jpg)
/newsdrum-in/media/media_files/G50q6xmH9Hhm9eUmYAty.jpg)
